Investor Relations

Corporate Profile

Helius Medical Technologies is a publicly traded company on the NASDAQ (HSDT) in the United States. Visit the About page to see how our company has developed, or see the PoNS™ page to learn about the science behind our flagship device.

Stock Quote & Chart

Minimum 15 minutes delayed. Source:

News Releases
October 18, 2024
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 14, 2024
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
September 30, 2024
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
August 16, 2024
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 12, 2024
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
August 6, 2024
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
June 17, 2024
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
May 29, 2024
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
May 23, 2024
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

Events

Presentations